Company intelligence / Profile preview

OxiWear

Arlington, Virginia, USA

Ownership: Private
Development stage: Other

Overview

OxiWear has developed an FDA-cleared wearable device for continuous, real-time measurement of blood oxygen saturation (SpO₂) and pulse rate, designed for use across all skin types and clinical or home settings. Its technology enables early detection of hypoxemia and provides immediate haptic/emergency messaging alerts, aiming to improve patient safety and quality of life for those with chronic respiratory conditions[1][3][4].

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Johns Hopkins University Hospital (clinical validation, expert endorsement)

Beyond the preview

Go deeper on OxiWear.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OxiWear.

Explore the full profile